Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Becton, Dickinson and Company BDXB
$50.14
На 18:02, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
14236544748.00000000
-
week52high
52.52
-
week52low
45.85
-
Revenue
18870000000
-
P/E TTM
0
-
Beta
0.56297500
-
EPS
6.33400000
-
Last Dividend
3.00000000
-
Next Earnings Date
06 авг 2020 г. в 12:30
Описание компании
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Piper Sandler | Neutral | Neutral | 06 мая 2022 г. |
Morgan Stanley | Overweight | Overweight | 06 мая 2022 г. |
Morgan Stanley | Overweight | Overweight | 11 апр 2022 г. |
Wells Fargo | Equal-Weight | Equal-Weight | 01 апр 2022 г. |
SVB Leerink | Market Perform | Market Perform | 06 авг 2021 г. |
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Byington Carrie L | A | 548 | 106 | 02 февр 2023 г. |
Jones Christopher Ian Montague | A | 9086 | 205 | 02 февр 2023 г. |
Fraser Claire | A | 22311 | 848 | 26 янв 2023 г. |
RING TIMOTHY M | A | 78830 | 848 | 24 янв 2023 г. |
SCOTT BERTRAM L | A | 33779 | 848 | 24 янв 2023 г. |
LARSEN MARSHALL O | A | 28919 | 848 | 24 янв 2023 г. |
Henderson Jeffrey William | A | 4653 | 848 | 24 янв 2023 г. |
Jones Christopher Ian Montague | A | 29171 | 848 | 24 янв 2023 г. |
BURZIK CATHERINE M | A | 13425 | 848 | 24 янв 2023 г. |
ECKERT R ANDREW | A | 6992 | 848 | 24 янв 2023 г. |
Свежие комментарии
Свежие комментарии